FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is application of first composition, containing pemetrexede and second composition, containing methoxyamine, for treatment of patient with diagnosed cancer, selected from lung cancer, colorectal cancer, ovary cancer, pancreatic cancer, kidney cancer, endometrial cancer, stomach cancer, lover cancer and breast cancer.
EFFECT: methoxyamine enhanced, increased or potentiated chemotherapeutic effect of antifolate anti-cancer agent; also demonstrated is unexpected reversing resistance to pemetrexede.
16 cl, 8 dwg,1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF ANTICANCER AGENTS | 2009 |
|
RU2516027C2 |
METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S, 4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(THIAZOLYL)-1,8-NAPHTHIRIDINE-3-CARBOXYLIC ACID FOR CANCER TREATMENT | 2006 |
|
RU2592231C2 |
CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2675270C2 |
COMBINED CHEMOTHERAPY | 2006 |
|
RU2429838C2 |
COMBINED CHEMOTHERAPY | 2010 |
|
RU2587013C2 |
METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THUASOLYL)-1,8-NAPHTHYDIRINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER | 2006 |
|
RU2428983C2 |
CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2823603C2 |
METHOD OF TREATMENT BY APPLICATION OF COMBINED THERAPY | 2010 |
|
RU2543348C2 |
SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT | 2001 |
|
RU2264217C2 |
ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE | 2013 |
|
RU2670974C2 |
Authors
Dates
2011-07-10—Published
2007-12-21—Filed